1. Kornblith PL, Walker MD, Cassady JR: Treatment of patients with supratentorial tumors-astrocytomas, oligodendrogliomas and optic gliomas. In: Kornblith PL, Walter MD, Cassady JR (eds) Neurologic Oncology. J.B. Lippincott Company, Philadelphia, 1987, pp 117?154
2. Robb RJ, Kutney RM, Chowdry V: Purification and partial sequence analysis of human T cell growth factor. Proc Natl Acad Sci (USA) 80: 5590?5595, 1983
3. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA: The lymphokine activated killer cell phenomena: lysis of NK resistant fresh solid tumor cells by IL-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823?1841, 1982
4. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avid FP, Leitman S, Linehan M, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson C, White DE: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. New Engl J Med 316: 889?897, 1987
5. Lillehei KO, Kruse CA, Mitchell DH, Johnson SD, McCleary EL: Adoptive immunotherapy of recurrent glioma using Interleukin-2 stimulated lymphocytes. Surgical Forum 40: 493?495, 1989